Primarily, the hyperglycemia in STZ-injected animals occurs due to acute pharmacological interruption of insulin secretion in the pancreas, which is completely different from the pathogenesis of type 2 diabetes, indicating that the molecular mechanism of lens opacification in the STZ animal model differs from that in type 2 diabetic humans. The gene discussed is INS; the disease is Hyperglycemia.